United States v. 84 Cartons, More or Less, of an Article of Drug Labeled in Part: "Femicin a New Scientific Compound"

KALBFLEISCH, District Judge.

This is an action in rem involving the alleged misbranding of an article called “Femicin.” The libel alleges that the article was misbranded when introduced into and while in interstate commerce, within the meaning of 21 U.S.C.A. § 352 (a) and 352(f) (1) and (2). The drug was seized in this district under authority of the Food and Drug Act, 21 U.S.C.A. § 301 et seq.

The manufacturer and claimant herein, Thayer Laboratories, has its main offices located in the ^Southern District of New York in the Borough of Manhattan. Pursuant to 21 U.S.C.A. § 334(a), claimant has…